An Open Label, Long Term Extension Study to Assess the Safety of Etanercept in the treatment of Psoriasis in Adult Subjects

1% effort 5 subjects

Awarded By

  • Amgen

Contributors

Amount

  • $46,716.00

Start/End

  • August 6, 2003 - August 31, 2005